Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1983-9-23
|
pubmed:abstractText |
T-1982 (cefbuperazone) was given intravenously to 21 children with the following acute bacterial infections; 13 cases of bronchopneumonia, 2 cases of urinary tract infection, 1 case of subcutaneous abscess, 1 case of cervical purulent lymphadenitis and acute tonsillitis, and 4 cases of acute bronchitis. Clinical effectiveness was obtained in 20 cases out of 21 cases and bacteriological effectiveness in 7 cases out of 8 cases. As for the side effects, 1 patient had asymptomatic eosinophilia, but no other laboratory abnormalities were observed. Above results suggest that T-1982 is a useful antibiotic for treating pediatric patients with various kinds of bacterial infections.
|
pubmed:language |
jpn
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0368-2781
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
36
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
855-61
|
pubmed:dateRevised |
2009-11-11
|
pubmed:meshHeading |
pubmed-meshheading:6348340-Anti-Bacterial Agents,
pubmed-meshheading:6348340-Cephalosporins,
pubmed-meshheading:6348340-Cephamycins,
pubmed-meshheading:6348340-Child,
pubmed-meshheading:6348340-Child, Preschool,
pubmed-meshheading:6348340-Drug Resistance, Microbial,
pubmed-meshheading:6348340-Escherichia coli,
pubmed-meshheading:6348340-Female,
pubmed-meshheading:6348340-Haemophilus influenzae,
pubmed-meshheading:6348340-Humans,
pubmed-meshheading:6348340-Infant,
pubmed-meshheading:6348340-Male,
pubmed-meshheading:6348340-Respiratory Tract Infections,
pubmed-meshheading:6348340-Staphylococcus aureus,
pubmed-meshheading:6348340-Urinary Tract Infections
|
pubmed:year |
1983
|
pubmed:articleTitle |
[Clinical experience with T-1982 (cefbuperazone) in the pediatric field].
|
pubmed:publicationType |
Journal Article,
English Abstract
|